2004

Survey Shows Lack of Confidence at FDA

December 18, 2004

Survey Shows Lack of Confidence at FDA About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency’s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey. Share this page

Read the full article →

Bill Aims to Protect Joint Patents

November 24, 2004

Bill Aims to Protect Joint Patents Patents that result from collaboration between universities and companies won new protections from legal challenge under legislation that passed Congress over the weekend.

Read the full article →

Trouble for California Cloning?

November 19, 2004

Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international cloning ban, vote on a new declaration introduced by Italy or delay voting once again. Just weeks after Californians voted for a $3 billion proposition to fund embryonic stem-cell research, which would include therapeutic cloning, [...]

Read the full article →

The Murky History of Merck’s Vioxx

November 18, 2004

The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent medical studies. Here are some key dates in the Vioxx saga:

Read the full article →

Contingency Plans Help Current Merck Crisis

November 17, 2004

Contingency Plans Help Current Merck Crisis : In the wake of Merck & Co.’s announcement to pull Vioxx off the market, the pharmaceutical giant pressed forward with plans to launch new products … The fact that companies such as Merck & Co. can quickly bounce back from troublesome corporate crises is a testament to their [...]

Read the full article →

Reviewing Drug Safety

November 9, 2004

Reviewing Drug Safety “The Food & Drug Administration has announced a major review of its system for monitoring the safety of drugs already on the market. FDA will sponsor an Institute of Medicine study of the agency’s safety monitoring procedures, and it will set up a formal program to make sure that the views of [...]

Read the full article →

The Stem Cell Gold Rush

November 4, 2004

The Stem Cell Gold Rush: Scientists around the country who study embryonic stem cells may be mourning four more years of President Bush’s restrictive funding policy, but California scientists are throwing a party, and top researchers in less-funded states are hoping for invitations.

Read the full article →

Financial Snapshot For September 2004

October 29, 2004

Financial Snapshot For September 2004 In need of a boost.

Read the full article →

Biotech: The “safe” drug bet?

October 28, 2004

Biotech: The “safe” drug bet? “Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”

Read the full article →

Biotech execs have a sense of humor about elusive profits

October 25, 2004

Biotech execs have a sense of humor about elusive profits When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.

Read the full article →

← Previous Entries